Top Purchases
The top purchases made by insiders yesterday. Remember, returns and win rates are calculated using the previous purchase trades by the insider.
Co-Founder at MDB Capital Holdings, LLC ($MDBH)
The Co-Founder purchased 2,100 shares at $6.19/share ($12,992.01 total) which increased their vested holdings by 2.4%. The current price is $6.08 (-1.8%). Their median purchase size is $26,500.00 and this is their 21st largest purchase out of 31 all time. (SEC Source)
Historic Returns
1m returns: -3% weighted | -20% median | 33% win rate (2/6)
3m returns: 28% weighted | 1% median | 50% win rate (3/6)
6m returns: 90% weighted | 59% median | 100% win rate (6/6)
1y returns: 282% weighted | 304% median | 100% win rate (6/6)
Director at Metsera, Inc. ($MTSR)
The Director purchased 789,998 shares at $18.00/share ($14.22M total) which increased their vested holdings by 9.3%. The current price is $27.80 (+54.4%). Their median purchase size is $7.23M and this is their 1st largest purchase out of 2 all time. (SEC Source)
Historic Returns
1m returns: 83% weighted | 83% median | 100% win rate (1/1)
3m returns: 36% weighted | 36% median | 100% win rate (1/1)
6m returns: 13% weighted | 13% median | 100% win rate (1/1)
1y returns: 11% weighted | 11% median | 100% win rate (1/1)
Note: 2 other insiders also purchased the stock
Chairman of the Board at FIDELITY D & D BANCORP INC ($FDBC)
The Chairman of the Board purchased 880 shares at $44.00/share ($38,720.00 total) which increased their vested holdings by 0.2%. The current price is $44.08 (+0.2%). Their median purchase size is $22,000.00 and this is their 8th largest purchase out of 27 all time. (SEC Source)
Historic Returns
1m returns: 5% weighted | 1% median | 69% win rate (9/13)
3m returns: 16% weighted | 6% median | 69% win rate (9/13)
6m returns: 30% weighted | 20% median | 83% win rate (10/12)
1y returns: 49% weighted | 18% median | 75% win rate (9/12)
Director at TRANSCAT INC ($TRNS)
The Director purchased 1,200 shares at $77.02/share ($92,427.00 total) which increased their vested holdings by 7.4%. The current price is $77.22 (+0.3%). Their median purchase size is $96,329.80 and this is their 3rd largest purchase out of 4 all time. (SEC Source)
Historic Returns
1m returns: 4% weighted | 2% median | 67% win rate (2/3)
3m returns: 12% weighted | 16% median | 67% win rate (2/3)
6m returns: 39% weighted | 24% median | 100% win rate (3/3)
1y returns: 16% weighted | 16% median | 100% win rate (3/3)
Top Sales
The top sales made by insiders yesterday. Remember, returns and win rates are calculated using the previous sell trades by the insider. For sell transactions, “win rate” is the percent of profitable trades. If the “win rate” is low, that means the stock typically falls after the insider sells.
Director at Dolby Laboratories, Inc. ($DLB)
The Director sold 1,000 shares at $84.90/share ($84,900.00 total) which decreased their vested holdings by 13.3%. The current price is $84.14 (-0.9%). Their median sale size is $84,745.50 and this is their 7th largest sale out of 16 all time. (SEC Source)
Historic Returns
1m returns: 4% weighted | 1% median | 60% win rate (9/15)
3m returns: -22% weighted | -28% median | 0% win rate (0/14)
6m returns: -31% weighted | -35% median | 14% win rate (2/14)
1y returns: -46% weighted | -5% median | 23% win rate (3/13)
Note: 1 other insiders also sold the stock
EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC ($IONS)
The EVP, Chief Development Officer sold 1,406 shares at $32.40/share ($45,561.29 total) which decreased their vested holdings by 1.4%. The current price is $32.13 (-0.8%). Their median sale size is $232K and this is their 22nd largest sale out of 25 all time. (SEC Source)
Historic Returns
1m returns: -14% weighted | -9% median | 12% win rate (2/16)
3m returns: -17% weighted | -14% median | 12% win rate (2/16)
6m returns: -25% weighted | -23% median | 14% win rate (2/14)
1y returns: -33% weighted | -22% median | 44% win rate (4/9)
Note: 6 other insiders also sold the stock
EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC ($IONS)
The EVP, Chf Clinical Develop Ofcr sold 1,484 shares at $32.20/share ($47,779.90 total) which decreased their vested holdings by 2.4%. The current price is $32.13 (-0.2%). Their median sale size is $201K and this is their 8th largest sale out of 8 all time. (SEC Source)
Historic Returns
1m returns: -4% weighted | -12% median | 20% win rate (1/5)
3m returns: -14% weighted | -14% median | 0% win rate (0/5)
6m returns: -5% weighted | -3% median | 20% win rate (1/5)
1y returns: -26% weighted | -29% median | 40% win rate (2/5)
Note: 6 other insiders also sold the stock
Disclaimer: The content provided by InsiderEdge™ is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. The historical performance noted in this post is not is not indicative of future results. Investing involves risk, including the potential loss of principal. Use the platform at your own risk and consult a financial advisor before making any investment decisions. In partnership with Yellowbrick Investing Inc.
